📊 PSNL Key Takeaways
Is Personalis, Inc. (PSNL) a Good Investment?
Personalis exhibits severe operational deterioration with declining revenue (-17.7% YoY), substantial operating losses (-207.9% margin), and negative free cash flow of -$25.7M. Despite a strong balance sheet with $73.6M cash and low leverage, the company is burning capital at an unsustainable rate with no visible path to profitability, indicating fundamental business model execution failure.
Personalis, Inc. Key Strengths (PSNL)
- Strong liquidity with 6.61x current ratio and $73.6M cash reserves providing operational runway
- Reasonable gross margin of 42.4% indicating viable core business economics at gross profit level
- Conservative capital structure with 0.08x debt-to-equity ratio limiting financial distress risk
PSNL Stock Risks: Personalis, Inc. Investment Risks
- Revenue contraction of 17.7% YoY indicates market share loss, demand destruction, or competitive pressures
- Massive operating losses (-32.2M) and negative operating cash flow (-22.5M) showing deteriorating unit economics
- Negative free cash flow of -$25.7M will deplete $73.6M cash reserves in approximately 3 years absent operational improvement
Key Metrics to Watch
- Revenue stabilization and trajectory toward positive YoY growth
- Operating cash flow path to positive territory as primary profitability indicator
- Operating margin improvement toward breakeven threshold
- Gross margin maintenance to confirm core business viability
Personalis, Inc. (PSNL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 6.61x current ratio provides a solid financial cushion.
PSNL Profit Margin, ROE & Profitability Analysis
PSNL vs Healthcare Sector: How Personalis, Inc. Compares
How Personalis, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Personalis, Inc. Stock Overvalued? PSNL Valuation Analysis 2026
Based on fundamental analysis, Personalis, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Personalis, Inc. Balance Sheet: PSNL Debt, Cash & Liquidity
PSNL Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Personalis, Inc.'s revenue has remained relatively flat over the 5-year period, with a 1% decline. The most recent EPS of $-1.37 indicates the company is currently unprofitable.
PSNL Revenue Growth, EPS Growth & YoY Performance
PSNL Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $15.5M | -$15.8M | $-0.18 |
| Q3 2025 | $14.5M | -$21.7M | $-0.24 |
| Q2 2025 | $17.2M | -$12.8M | $-0.23 |
| Q1 2025 | $19.5M | -$13.0M | $-0.18 |
| Q3 2024 | $18.2M | -$29.1M | $-0.60 |
| Q2 2024 | $16.7M | -$12.8M | $-0.24 |
| Q1 2024 | $18.9M | -$13.0M | $-0.26 |
| Q3 2023 | $14.9M | -$26.5M | $-0.58 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Personalis, Inc. Dividends, Buybacks & Capital Allocation
PSNL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Personalis, Inc. (CIK: 0001527753)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| May 29, 2026 | 4 | xslF345X06/form4-05292026_080501.xml | View → |
| May 29, 2026 | 4 | xslF345X06/form4-05302026_120502.xml | View → |
| May 20, 2026 | 8-K | psnl-20260519.htm | View → |
| May 14, 2026 | 4 | xslF345X06/form4-05142026_090542.xml | View → |
| May 14, 2026 | 4 | xslF345X06/form4-05142026_090531.xml | View → |
❓ Frequently Asked Questions about PSNL
What is the AI rating for PSNL?
Personalis, Inc. (PSNL) has an AI grade of D with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PSNL's key strengths?
Claude: Strong liquidity with 6.61x current ratio and $73.6M cash reserves providing operational runway. Reasonable gross margin of 42.4% indicating viable core business economics at gross profit level.
What are the risks of investing in PSNL?
Claude: Revenue contraction of 17.7% YoY indicates market share loss, demand destruction, or competitive pressures. Massive operating losses (-32.2M) and negative operating cash flow (-22.5M) showing deteriorating unit economics.
What is PSNL's revenue and growth?
Personalis, Inc. reported revenue of $15.5M.
Does PSNL pay dividends?
Personalis, Inc. does not currently pay dividends.
Where can I find PSNL SEC filings?
Official SEC filings for Personalis, Inc. (CIK: 0001527753) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PSNL's EPS?
Personalis, Inc. has a diluted EPS of $-0.29.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PSNL's fundamental grade?
Based on our AI fundamental analysis in May 2026, Personalis, Inc. has a D grade with 85% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PSNL stock overvalued or undervalued?
Valuation metrics for PSNL: ROE of -11.8% (sector avg: 15%), net margin of -194.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PSNL's AI grade for 2026?
Our dual AI analysis gives Personalis, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PSNL's free cash flow?
Personalis, Inc.'s operating cash flow is $-22.5M, with capital expenditures of $3.2M. FCF margin is -165.9%.
How does PSNL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -194.1% (avg: 12%), ROE -11.8% (avg: 15%), current ratio 6.61 (avg: 2).